Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-C-2684 | RX-3117 CAS:865838-26-2 | RX-3117(TV-1360;Fluorocyclopentenylcytosine)is novel a cytidine analog;shows anticancer activity in several cancer cell lines,including gemcitabine-resistant variants. | price> |
R-R-4384 | L-DOPA-2,5,6-d3 CAS No.53587-29-4 | L-DOPA-2,5,6-d3/CAS No.53587-29-4 is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. | price> |
R-C-2685 | LY2334737 CAS:892128-60-8 | LY2334737 is an nucleoside analog and is an orally active prodrug of Gemcitabine.LY2334737 exhibits inhibitory activity against enterovirus A71(EV-A71)infection.LY2334737 has antiviral and anticancer effects. | price> |
R-R-4385 | Propionylpromazine-d6 hydrochloride CAS No.1262770-67-1 | Propionylpromazine-d6 (hydrochloride)/CAS No.1262770-67-1 is the deuterium labeled Propionylpromazine hydrochloride. Propionylpromazine hydrochloride (Propiopromazine hydrochloride), a dopamine receptor D2 (DRD2) antagonist, can be used in the research of Parkinson disease. | price> |
R-C-2686 | Evofosfamide (TH-302) CAS:918633-87-1 | Evofosfamide(TH-302)is a hypoxia-activated prodrug with IC50 of 10μM and 1000 μM in hypoxia(N2)and normoxia(21% O2),respectively. | price> |
R-R-4386 | PD 168568 dihydrochloride CAS No.1782532-06-2 | PD 168568 dihydrochloride/CAS No.1782532-06-2 is a orally active and potent dopamine receptor D4 (DRD4) antagonist. PD 168568 dihydrochloride contains an isoindolinone and is selective for the D4 receptor versus D2 and D3, with Ki values of 8.8, 1842, and 2682 nM, respectively. PD 168568 dihydrochloride can be used for glioblastoma (GBM) research. | price> |
R-R-4387 | Amisulpride-d5 CAS No.1216626-17-3 | Amisulpride-d5/CAS No.1216626-17-3 is the deuterium labeled Amisulpride. Amisulpride is a dopamine D2/D3 receptor antagonist with Kis of 2.8 and 3.2 nM for human dopamine D2 and D3, respectively. | price> |
R-R-4388 | Cabergoline-d5 CAS No.1426173-20-7 | Cabergoline-d5/CAS No.1426173-20-7 is the deuterium labeled Cabergoline. Cabergoline is an ergot derived-dopamine D2-like receptor agonist that has high affinity for D2, D3, and 5-HT2B receptors (Ki=0.7, 1.5, and 1.2, respectively). | price> |
R-C-2689 | Calyculin A CAS:101932-71-2 | Calyculin A is a natural,cell-permeable inhibitor of the serine-threonine protein phosphatases(PP)PP1 and PP2A(IC50s=0.3-0.7 and 0.5-1nM,respectively).It is without significant effect against PP2B,PP2C,and PP4.2 Through its effects on PP1 and PP2A,calyculin A has been shown to either promote or inhibit cancer cell growth in tumor cell lines and animal models. | price> |
R-R-4389 | FAUC 365 CAS No.474432-66-1 | FAUC 365/CAS No.474432-66-1 is a highly dopamine D3 receptor-selective antagonist with Ki values of 0.5 nM, 340, 2600, and 3600 nM at D3, D4.4, D2short, and D2Long receptors, respectively. FAUC 365 can be used for the research of schizophrenia, and Parkinson disease. | price> |
R-C-2690 | SGI-1027 CAS:1020149-73-8 | SGI-1027 is a DNA methyltransferase(DNMT)inhibitor,with IC50s of 7.5μM,8μM, and 12.5 μM for DNMT3B,DNMT3A,and DNMT1 with poly(dI-dC)as substrate. | price> |
R-R-4390 | SK609 hydrochloride CAS No.1092797-77-7 | SK609 hydrochloride/CAS No.1092797-77-7 is a dopamine D3 receptor (D3R) selective agonist with an EC50 of 1109 nM. SK609 hydrochloride has the potential for parkinson research. | price> |
R-C-2691 | LB-100 CAS:1026680-07-8 | LB-100 is a protein phosphatase 2A(PP2A)inhibitor.LB-100 sensitizes hepatocellular carcinoma cells to the effects of sorafenib during hypoxia by activation of Smad3 phosphorylation.LB-100 enhanced the effects of sorafenib in HCC cells only during hypoxic environments. | price> |
R-R-4391 | Levosulpiride-d3 CAS No.124020-27-5 | Levosulpiride-d3/CAS No.124020-27-5 is the deuterium labeled Levosulpiride. Levosulpiride (RV-12309) is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic agent of the benzamide class. | price> |
R-C-2692 | NVP-BSK805 CAS:1092499-93-8 | NVP-BSK805 is a JAK2 inhibor,which displays more than 20-fold selectivity towards JAK2 in vitro,as well as excellent selectivity in broader kinase profiling.In vivo,NVP-BSK805 exhibited good oral bioavailability and a long half-life. | price> |
R-R-4392 | CP 226269 CAS No.220941-93-5 | CP 226269/CAS No.220941-93-5 is a potent dopamine D4 receptor agonist that induces calcium flux with EC50 of 32.0 nM. CP 226269 can be used in the research of schizophrenia and other related diseases. | price> |
R-C-2693 | CCT137690 CAS:1095382-05-0 | CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15,25,and 19nM for aurora A,B and C,respectively. | price> |
R-R-4393 | FAUC 213 CAS No.337972-47-1 | FAUC 213/CAS No.337972-47-1 is an orally active and highly selective dopamine D4 receptor complete antagonist with a Ki of 2.2 nM for hD4.4. FAUC 213 has less activity on D2 and D3 receptors (Kis of 3.4 μM, 5.3 μM for hD2, hD3, respectively). FAUC 213 can cross the blood-brain barrier (BBB). FAUC 213 exhibits atypical antipsychotic characteristic. | price> |
R-C-2694 | BYK 204165 CAS:1104546-89-5 | BYK204165 is a potent and selective PARP1 inhibitor. BYK204165 inhibits cell-free recombinant human PARP-1(hPARP-1)with a pIC50 of 7.35(pKi=7.05),and murine PARP-2(mPARP-2)with a pIC50 of 5.38,respectively.BYK204165 displays 100-fold selectivity for PARP-1. | price> |
R-R-4394 | BP 897 hydrochloride CAS No.314776-92-6 | BP 897 hydrochloride/CAS No.314776-92-6 is a potent and partial dopamine D3 receptor agonist and a weak D2 receptor antagonist. BP 897 hydrochloride displays a high affinity at the dopamine D3 receptor (Ki=0.92 nM) and a 70 times lower affinity at the D2 receptor (Ki=61 nM). | price> |